Prescription benefit updates Large group
|
|
- Rosaline Phelps
- 6 years ago
- Views:
Transcription
1 Prescription benefit updates Large group Moda Health s prescription program is a pharmacy benefit that offers members a choice of safe and effective medication treatments. The program also helps you save money on prescription drugs. Periodically, medication coverage changes will occur. These changes allow us to maintain a comprehensive benefit and provide you with an open formulary and choice, and support the program s ongoing stability. Our prescription program uses a tiered copay/coinsurance system. You and your doctor can choose between the value, select, preferred or brand tier medications. What you pay for a drug depends on your plan. Please review the following expected pharmacy coverage updates. Please note, this information could change and does not represent every potential update to your benefits. Refer to your member handbook for specific tier and coverage information. Questions? Call our Pharmacy Customer Service team toll-free at Value tier Select tier Preferred tier Brand tier Value medications include commonly prescribed medications used to treat chronic medical conditions and preserve health. Plans that do not include a value tier benefit will have medications categorized under this tier paid at the select or preferred tier copay/coinsurance levels. Generic medications are considered by physicians and pharmacists to be therapeutically the same as brand name alternatives and at the most favorable cost. Generic medications must contain the same active ingredient as their brand name counterparts and be identical in strength, dosage and format. This benefit level may also include select brand medications that have been identified as favorable from a clinical and cost effective perspective. The preferred tier includes brand and specialty brand name medications that have been reviewed by Moda Health and found to be clinically effective at a favorable cost when compared with other medications in the same category. This tier may also include generic medications that have been found to have the same clinical outcomes as their more costeffective generic counterparts in the same category. If your plan does not include a preferred tier, then those medications will be paid at the select or brand tier copay/coinsurance level. This tier includes brand name medications that have been reviewed by Moda Health and found not to have a significant therapeutic advantage over their preferred tier counterparts.
2 Prescription coverage updates These expected Moda Health prescription tier and coverage updates go into effect for Product name Medication class Effective date Update Aciphex, Aciphex Sprinkle (rabeprazole sodium) Add age restriction on Aciphex and Aciphex Sprinkle as follows: Ages 18 years of age or older medication is excluded due to Analpram HC (hydrocortisone/pramoxine) Lower Disorders - Bowel Inflammat Changing from Analpram HC from preferred brand (Tier 2) to Anaspaz Changing from Anaspaz from preferred brand (Tier 2) to Anucort-HC, Anusol-HC (hydrocortisone acetate) Lower Disorders - Bowel Inflammat Changing Anucort-HC and Anusol-HC to excluded due to DESI Auvi-Q (epinephrine) Miscellaneous Agents Changing Auvi-Q from preferred brand (Tier 2) to nonpreferred brand (Tier 3). Beconase AQ (beclomethasone dipropionate) Nasal Steroid Add age restriction on Beconase AQ as follows: Ages 18 years of age or older medication is excluded due to Butrans (buprenorphine) Pain Management - Analgesics Changing Butrans from preferred brand (Tier 2) to Choline Mag Trisalicylate (choline salicyl/mag salicylate) Pain Management - Analgesics Changing Choline Mag Trisalicylate to excluded due to DESI Cortane-B (hydrocortisone/pramoxine/cxyl) Ear - General Disorders Changing Cortane-B to excluded due to DESI Covaryx, Covaryx H.S. (estrogen,ester/metestosterone) Hormonal Deficiency Changing Covaryx and Covaryx H.S. to excluded due to DESI Cytra-K (potassium citrate/citric acid) Urinary Tract - Functional Disorders Changing Cytra-K to excluded due to DESI Dexilant (dexlansoprazole) Add age restriction on Dexilant as follows: Ages 18 Disalcid (salsalate) Pain Management - Analgesics Changing Disalcid from preferred brand (Tier 2) to Donnatal (phenobarb/hyoscy/atropine/sc op) Changing Donnatal to excluded due to DESI
3 Product name Medication class Effective date Update Doxycycline Hyclate 100mg (tablet, capsule and tablet DR) Infectious - Bacterial Changing Doxycycline Hyclate 100mg tablet, capsule and tablet DR from preferred brand (Tier 2) to nonpreferred brand (Tier 3). EEMT, EEMT H.S. (estrogen,ester/metestosterone) Epiduo Forte (adapalene/benzoyl peroxide) Hormonal Deficiency Acne Agents, Topical Changing EEMT and EEMT H.S. to excluded due to DESI Add step therapy requirement on Epiduo Forte as follows: Must try/fail generic tretinoin or adapalene Epipen, Epipen JR (Epinephrine) Miscellaneous Agents Changing Epipen and Epipen JR from preferred brand (Tier 2) to Fenortho (fenoprofen calcium) Inflammatory Changing Fenortho from preferred brand (Tier 2) to Flonase (fluticasone propionate) Nasal Steroid Add age restriction on Flonase as follows: Ages 18 Flunisolide spray Nasal Steroid Add age restriction on Flunisolide spray as follows: Ages 18 years of age or older medication is excluded due to Fluoritab (fluoride (sodium)) Changing Fluoritab from preferred brand (Tier 2) to Fluvastatin, Fluvastatin ER Cardiovascular - Lipid Irregularity Add step therapy requirement on fluvastatin and fluvastatin ER for a trial of one of the following generics: atorvastatin, lovastatin, pravastatin, rosuvastatin, or simvastatin. Guaifenesin DAC (pseudoephed/codeine/guaifen) Cough And Cold Changing Guaifenesin DAC to excluded due to DESI Hemmorex-HC (hydrocortisone acetate) Antiinflammatory Changing Hemmorex-HC from preferred brand (Tier 2) to Hydrocortisone-Iodoquinol Acne Changing Hydrocortisone-Iodoquinol to excluded due to DESI Hydrocortisone-Pramoxine Lower Disorders - Bowel Inflammat Changing Hydrocortisone-Pramoxine to excluded due to DESI Hydrocortisone-Pramoxine HCl Miscellaneous Changing Hydrocortisone-Pramoxine HCl to excluded due to DESI Hyosyne Changing Hyosyne to excluded due to DESI Invokamet, Invokamet XR (canagliflozin/metformin hcl) Invokana (canagliflozin) Diabetes Diabetes Changing Invokamet and Invokamet XR from preferred brand (Tier 2) to non-preferred brand (Tier 3). Changing Invokana from preferred brand (Tier 2) to
4 Product name Medication class Effective date Update Isopto Atropine (atropine sulfate) Eye - Glaucoma Changing Isopto Atropine from preferred brand (Tier 2) to Isopto Carpine (pilocarpine hcl) Eye - Glaucoma Changing Isopto Carpine from preferred brand (Tier 2) to Ketorolac Tromethamine 0.4% Drops Eye - General Disorders Changing Ketorolac Tromethamine 0.4% Drops from Select (Tier 1) to preferred brand (Tier 2). Klor-Con (Packet) (potassium chloride) Electrolyte Regulation Changing Klor-Con packets from preferred brand (Tier 2) to Klor-Con-Ef (potassium bicarbonate/cit ac) Electrolyte Regulation Changing Klor-Con-Ef from preferred brand (Tier 2) to Levbid Changing Levbid from preferred brand (Tier 2) to Levsin, Levsin-SL Changing Levsin and Levsin-SL from preferred brand (Tier 2) to Lodine (etodolac) Inflammatory Changing Lodine from preferred brand (Tier 2) to Ludent Fluoride (fluoride (sodium)) Changing Ludent Fluoride from preferred brand (Tier 2) to Nasonex (mometasone furoate) Nasal Steroid Add age restriction on Nasonex as follows: Ages 18 Nexium (esomeprazole magnesium) Add age restriction on Nexium as follows: Ages 18 Nodolor (isomethept/dichlphn/acetamin op) Pain Management - Analgesics Changing Nodolor to excluded due to DESI Nulev Changing Nulev from preferred brand (Tier 2) to nonpreferred brand (Tier 3). Omeppi (omeprazole/sodium bicarbonate) Add age restriction on Omeppi as follows: Ages 18 Omnaris (ciclesonide) Nasal Steroid Add age restriction on Omnaris as follows: Ages 18 Phenergan (promethazine hcl) Antiemesis/ Antivertigo Changing Phenergan from preferred brand (Tier 2) to PNV-DHA (prenatal 47/iron/folate 1/dha) Changing PNV-DHA to excluded due to DESI
5 Product name Medication class Effective date Update PNV-Select (prenatal,calc.40/iron/folate 1) Changing PNV-Select to excluded due to DESI Potaba (potassium aminobenzoate) Changing Potaba to excluded due to DESI Pramosone (hydrocortisone/pramoxine) Miscellaneous Changing Pramosone from preferred brand (Tier 2) to Prevacid (lansoprazole) Add age restriction on Prevacid as follows: Ages 18 Prilosec (omeprazole magnesium) Add age restriction on Prilosec as follows: Ages 18 Proctocort (Supp. Rect) (hydrocortisone acetate) Lower Disorders - Bowel Inflammat Changing Proctocort rectal suppositories to excluded due to DESI Proctocort (Cream) (hydrocortisone) Antiinflammatory Changing Proctocort cream from preferred brand (Tier 2) to Protonix (pantoprazole sodium) Add age restriction on Protonix as follows: Ages 18 Pyridium (phenazopyridine hcl) Urinary Tract - Functional Disorders Changing Pyridium from preferred brand (Tier 2) to Rectacort-HC (hydrocortisone acetate) Antiinflammatory Changing Rectacort-HC from preferred brand (Tier 2) to Revatio (sildenafil citrate) Cardiovascular - Hypertension Changing Revatio from preferred brand (Tier 2) to Scalacort (hydrocortisone) Antiinflammatory Changing Scalacort from preferred brand (Tier 2) to Symax Changing Symax from preferred brand (Tier 2) to Symax-SL Changing Symax-SL to excluded due to DESI Symax-SR Changing Symax-SR from preferred brand (Tier 2) to Terconazole 0.04% Cream/Appl Vaginal Antifungals Terconazole 0.08% Cream/Appl Vaginal Antifungals Change quantity limit on Terconazole 0.04% to 45 gm per 30 days. Change quantity limit on Terconazole 0.08% to 20 gm per 30 days.
6 Product name Medication class Effective date Update Terconazole 80mg Supp.Vag Vaginal Antifungals Change quantity limit on Terconazole 80mg suppositories to 3 suppositories per 30 days. Tretinoin Microsphere Acne Add step therapy requirement on Tretinoin Microsphere for a trial of generic tretinoin or adapalene. Tretin-X (tretinoin) Acne Add step therapy requirement on Tretin-X for a trial of generic tretinoin or adapalene. Urelle (meth/meblue/sod phos/ psal/hyos) Infectious - Bacterial Changing Urelle to excluded due to DESI classification as less-than-effective. Valcyte (valganciclovir hcl) Infectious - Viral Changing Valcyte from preferred brand (Tier 2) to Xyzbac (multivit34/folic ac/nadh/coq10) Changing Xyzbac to excluded due to vitamin exclusion (see member handbook). Zegerid (omeprazole/sodium bicarbonate) Add age restriction on Zegerid as follows: Ages 18 Zithromax (azithromycin) Infectious - Bacterial Changing Zithromax from preferred brand (Tier 2) to This document is provided for informational purposes only, and is intended as a quick reference. For cost and further details of the coverage, including exclusions, prior authorization requirements, any reduction or limitations and the terms under which the policy may be continued in force, contact your producer or Moda Health. Copyright 2014 Moda, Inc. All Rights Reserved. Health plans in Oregon and Alaska provided by Moda Health Plan, Inc.
7
8
Additional drug coverage
Additional drug coverage Bonus Drug List The North Carolina State Health Plan for Teachers and State Employees offers a bonus drug list. The prescription drugs in this list are covered in addition to the
More informationOregon Health Plan prescription benefit updates
Oregon Health Plan prescription benefit updates EOCCO s prescription program is a pharmacy benefit that offers members a choice of safe and effective medication treatments. The program also helps you save
More informationMAXIMUM ALLOWABLE COST POLICY CHANGES DECEMBER 5, 2016 QUESTIONS AND ANSWERS
MAXIMUM ALLOWABLE COST POLICY CHANGES DECEMBER 5, 2016 QUESTIONS AND ANSWERS The November 22, 2016 Mid-Year Financial Report referred to changes to drug coverage under the Saskatchewan Drug Plan. What
More informationAdditional Drug Coverage
Additional Drug Coverage Additional prescription drug coverage Your plan includes extra coverage for certain drugs and supplies as shown below. These drugs are either not generally covered under Medicare
More informationAdditional Drug Coverage
Additional Drug Coverage Bonus Drug List Your employer group or plan sponsor offers a bonus drug list. The prescription drugs on this list are covered in addition to the drugs on the plan s drug list (formulary).
More informationAdditional DRUG COVERAGE
Additional DRUG COVERAGE Additional prescription drug coverage Your plan includes extra coverage for certain drugs as shown below. These drugs are either not generally covered under Medicare Part D or
More informationAdditional drug coverage
Additional drug coverage Additional prescription drug coverage Your plan includes extra coverage for certain drugs as shown below. These drugs are either not generally covered under Medicare Part D or
More informationAdditional DRUG COVERAGE
Additional DRUG COVERAGE Bonus Drug List Your plan sponsor (employer, union or trust) offers a bonus drug list. The prescription drugs in this list are covered in addition to the drugs in the plan s formulary
More informationAdditional drug coverage
Additional drug coverage Bonus Drug List Your plan sponsor (employer, union or trust) offers a bonus drug list. The prescription drugs on this list are covered in addition to the drugs on the plan s drug
More informationAdditional DRUG COVERAGE
Additional DRUG COVERAGE Lower-cost Medicare prescription drugs Your plan covers some of your Medicare prescription drugs and supplies at a lower drug tier or co-pay than in your formulary (drug list).
More informationProton Pump Inhibitors
Market DC Proton Pump Inhibitors Override(s) Prior Authorization Quantity Limit** Approval Duration Preferred PPI: No Prior Authorization required Preferred PPI quantity override: Lifetime Non-Preferred
More informationAdditional Drug Coverage
Additional Drug Coverage Additional prescription drug coverage Your plan includes extra coverage for certain supplies as shown below. These supplies are either not generally covered under Medicare Part
More informationAdditional drug coverage
Additional drug coverage Additional prescription drug coverage Your plan includes extra coverage for certain drugs as shown below. These drugs are either not generally covered under Medicare Part D or
More information2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009
2018 PDP Premier Step Therapy Document September 2018 Aggrenox Y0114_18_33144_I_009 aspirin 25 mg-dipyridamole 200 mg capsule,ext.release 12 hr multiphase drug may be given. Step 1 Drug(s): clopidigrel.
More informationPrescription benefit updates Large group
Prescription benefit updates Large group Moda Health s prescription program is a pharmacy benefit that offers members a choice of safe effective medication treatments. The program also helps you save money
More informationGenerics. Lead with. P r e s c r i p t i o n S t e p T h e r a p y P r o g r a m
Lead with Generics P r e s c r i p t i o n S t e p T h e r a p y P r o g r a m WWW.BCBSLA.COM 04HQ3972 5/09 Blue Cross and Blue Shield of Louisiana incorporated as Louisiana Health Service & Indemnity
More informationPharmacy Coverage Guidelines are subject to change as new information becomes available.
PROTON PUMP INHIBITORS, NON-PREFERRED FORMS: ACIPHEX (rabeprazole sodium EC) oral tablet ACIPHEX SPRINKLE (rabeprazole sodium DR) oral capsule ESOMEPRAZOLE STRONTIUM (esomeprazole strontium DR) oral capsule
More informationHigh-Cost Drug Exclusions
PHARMACY SERVICES High-Cost Exclusions The high cost medications listed below are excluded from coverage because lower cost similar alternatives are available. To help you get the best health benefit at
More informationBLUE SHIELD OF CALIFORNIA JUNE 2016 PLUS DRUG FORMULARY CHANGES
BLUE SHIELD OF CALIFORNIA JUNE 2016 PLUS DRUG FORMULARY CHANGES Blue Shield is committed to covering safe, effective and affordable medications, so we regularly review and update our drug formularies.
More informationProton Pump Inhibitors (PPIs) (Sherwood Employer Group)
Proton Pump Inhibitors (PPIs) (Sherwood Employer Group) BCBSKS will review Prior Authorization requests Prior Authorization Form: https://www.bcbsks.com/customerservice/forms/pdf/priorauth-6058ks-st-ippi.pdf
More informationHigh-Cost Drug Exclusions
Pharmacy Services High-Cost Exclusions The high cost medications listed below are excluded from coverage because lower cost similar alternatives are available. To help you get the best health benefit at
More informationPHARMA-MEDIC SERVICES INC. POLICY MANUAL
PHARMA-MEDIC SERVICES INC. POLICY MANUAL SUBJECT: INDEX: P.5.a.iii Automatic-Therapeutic Substitution DATE: June 1/2011 REVISED: March 2, 2015., Feb 2017. PROCEDURE: 1. Long term care homes use the Manitoba
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Step Therapy Reference Number: HIM.PA.109 Effective Date: 08.01.17 Last Review Date: 05.18 Line of Business: Health Insurance Marketplace Revision Log See Important Reminder at the end
More informationYour prescription benefit updates Formulary Updates - Effective January 1, 2019
Your prescription benefit updates Formulary Updates - Effective January 1, 2019 Medications are grouped by the conditions they treat. Each medication is placed in a tier that shows the amount you will
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Step Therapy Reference Number: HIM.PA.109 Effective Date: 08.01.17 Last Review Date: 05.18 Line of Business: Health Insurance Marketplace Revision Log See Important Reminder at the end
More information1/1/2019 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS
1/1/2019 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS Effective 1/1/19, Cigna is making changes to our formularies that may impact medication coverage for customers at your pharmacy. We have included a
More informationALLERGIC RHINITIS-NASAL
ALLERGIC RHINITIS-NASAL FLUNISOLIDE Patient needs to have paid claims for any one of the following Step 1 drugs: NasaCort OTC, fluticasone Rx, fluticasone OTC, Budesonide OTC. Prior to filling the Step
More informationGenerics. Lead with. Prescription Step Therapy Program
Lead with Generics Prescription Step Therapy Program WWW.BCBSLA.COM 04HQ3972 R11/10 Blue Cross and Blue Shield of Louisiana incorporated as Louisiana Health Service & Indemnity Company GENERIC DRUGS: A
More informationDrug Formulary Update, April 2017 Commercial and State Programs
Drug Formulary Update, April 2017 Commercial and State Programs Updates to the HealthPartners Commercial and State Program Drug Formularies are listed below. Updates apply to all Commercial groups (PreferredRx,
More informationProton Pump Inhibitors. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.50.01 Subject: Proton Pump Inhibitors Page: 1 of 6 Last Review Date: June 24, 2015 Proton Pump Inhibitors
More informationPRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select April 1, 2018 Updates Drug Name adapalene-benzoyl-peroxide Gel 0.1-2.5% (Brand = Epiduo ) prasugrel hcl (Brand = Effient ) vigabatrin pak 500 mg (Brand
More informationPharmacy Program Updates: Quarterly Pharmacy Changes Effective July 1, 2017
Pharmacy Program Updates: Quarterly Pharmacy Changes Effective July 1, 2017 DRUG LIST CHANGES Based on the availability of new prescription medications and Prime s National Pharmacy and Therapeutics Committee
More informationMercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria
ALBENDAZOLE Mercy Care ALBENZA TABLET 200 MG ORAL Refer to PA Guideline for approval criteria 1 BRIMONIDINE-TIMOLOL COMBIGAN SOLUTION 0.2-0.5 % OPHTHALMIC Requires use of separate ingredients for at least
More informationDEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL
DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL I. UNIFORM FORMULARY REVIEW PROCESS Under 10 United States Code
More informationSection I contains changes to the Highmark Select/Choice Formulary.
June 2007 2 nd Quarter Update: Highmark Drug Formulary Enclosed is the 2 nd Quarter 2007 update to the Highmark Drug Formulary and pharmaceutical management procedures. The Formulary and pharmaceutical
More informationCoverage Period: 01/01/ /31/2018 Coverage for: Individual and/or Family Plan: Healthy Rewards HSA
This is only a summary of your GatorCare pharmacy benefits. If you would like detail about your coverage and costs, you can get the complete terms in the policy or plan document at gatorcare.magellanrx.com/member
More informationDRUG SCHEDULES REGULATION CHANGES JUNE 2018
DRUG SCHEDULES REGULATION CHANGES JUNE 2018 The following amendments to the Schedules to the Drug Schedules Regulation made under the Pharmacy Operations and Drug Scheduling Act came into effect on June
More informationPRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select April 1, 2018 Updates Drug Name adapalene-benzoyl-peroxide Gel 0.1-2.5% (Brand = Epiduo ) prasugrel hcl (Brand = Effient ) vigabatrin pak 500 mg (Brand
More informationWellCare s South Carolina Preferred Drug List Update
WellCare s South Carolina Preferred Drug List Update This is a list of changes to our preferred drug list. These are a result of the latest WellCare Pharmacy & Therapeutics meeting held on 09/03/2015.
More informationDrug Class Monograph
Drug Class Monograph Class: Proton Pump Inhibitors Drugs: Aciphex Sprinkle (rabeprazole), Dexilant (dexlansoprazole), Lansoprazole, Nexium (esomeprazole capsule, esomeprazole granules), Omeprazole, Pantoprazole,
More informationCRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.
ADHD STIMULANTS ATOMOXETINE HCL, DEXEDRINE 10 MG TABLET, DEXEDRINE 5 MG TABLET, DEXMETHYLPHENIDATE HCL, DEXMETHYLPHENIDATE HCL ER, DEXTROAMPHETAMINE 10 MG TAB, DEXTROAMPHETAMINE 5 MG TAB, DEXTROAMPHETAMINE
More informationPharmacy benefit guide
FlexRx SM 5-Tier Pharmacy benefit guide 1 Welcome to FlexRx The NHP FlexRx SM program is built for choice, savings, and convenience with benefits including: Low-cost drug tier for many common medications
More informationCHICAGO REGIONAL COUNCIL OF CARPENTERS WELFARE FUND RETIREE PRESCRIPTION DRUG BENEFITS October 2013
CHICAGO REGIONAL COUNCIL OF CARPENTERS WELFARE FUND RETIREE PRESCRIPTION DRUG BENEFITS October 2013 How to Use the Prescription Drug Program The Chicago Regional Council of Carpenters Welfare Fund has
More informationPrepared for Regence BlueCross BlueShield of Oregon Producers Only. Not intended for distribution to Regence consumers or members.
Revised date: 10/17/16 Issue Brief: Jan. 1, 2017, Formulary Changes OmedaRx regularly evaluates the performance and impact of medications using one of the most rigorous, evidence-based assessment processes
More informationPage 1 of 5 Official reprint from UpToDate www.uptodate.com 2017 UpToDate Patient education: Acid reflux (gastroesophageal reflux disease) in adults (The Basics) Written by the doctors and editors at UpToDate
More informationAmitriptyline Hydrochloride Heart Health & BP Amlodipine Besylate 5mg Norvasc Antibiotics Amoxicillin 500 mg Amoxil
School Corp Formulary Antiviral Acyclovir 400mg Zovirax Asthma Advair Diskus Diskus 250/50 Fluticasone/Salmeterol Asthma Albuterol Sulfate 2.5 mg/3 ml Proventil Arthritis and Pain Allendronate Sodium 70
More informationAETNA BETTER HEALTH January 2017 Formulary Change(s)
AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on February 1, 2017 Drug Name, Strength, Dosage Form IVERMECTIN 3 MG TABLET
More informationAETNA BETTER HEALTH January 2017 Formulary Change(s)
AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on March 1, 2017 Drug Name, Strength, Dosage Form ALFUZOSIN HCL ER 10
More informationCoverage Period: Coverage for: Plans: This is only a summary of your GatorCare pharmacy benefits. Coinsurance: you your Dependent Copayment: you
This is only a summary of your GatorCare pharmacy benefits. If you would like detail about your coverage and costs, you can get the complete terms in the policy or plan document at gatorcare.magellanrx.com/member
More information2017 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements
2017 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements AlohaCare requires you to first try one drug to treat your medical condition before we will cover another drug for
More informationRelative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*
Allergy Chlorpheniramine Tablet* Diphenhydramine Tablet* Diphenhydramine Liquid* Loratadine Tablet* Cetirizine Tablet* Loratadine 10mg ODT* Less than $10 Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*
More informationRxBlue 2010 ST Criteria
RxBlue 2010 ST Criteria ANTIDEPRESSANTS - SARAFEM... 10 FLUOXETINE HCL... 10 SARAFEM... 10 SELFEMRA... 10 ANTIDEPRESSANTS- SSRI, SNRI... 11 CELEXA... 11 CITALOPRAM... 11 CYMBALTA... 11 EFFEXOR XR... 11
More informationANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS
SR. NO 1 ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS Paracetamol 500 mg, Phenylephrine HCL 5 mg With Chlorpheniramine Maleate 2 mg & Caffeine 30 mg Tablets 2 Salbutamol Tablets BP 2 mg 3 Salbutamol Tablets
More informationOral Agents. Fml Limits. Available Strengths NF NF
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Allergy Medications LAST REVIEW: 9/12/2017 THERAPEUTIC CLASS: Rheumatologic/Immunologic REVIEW HISTORY: 9/16, 5/15, 9/14
More informationAmitriptyline Hydrochloride Heart Health & BP Amlodipine Besylate 5mg Norvasc Antibiotics Amoxicillin 500 mg Amoxil
Antiviral Acyclovir 400mg Zovirax Asthma Advair Diskus Diskus 250/50 Fluticasone/Salmeterol Asthma Albuterol Sulfate 2.5 mg/3 ml Proventil Arthritis and Pain Allendronate Sodium 70 mg Fosamax Arthritis
More informationProton Pump Inhibitors. Description. Section: Prescription Drugs Effective Date: July 1, 2014
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.09.01 Subject: Proton Pump Inhibitors Page: 1 of 7 Last Review Date: June 12, 2014 Proton Pump Inhibitors
More informationUF Decision Report FY06-07 Beneficiary Advisory Panel 10 Jan 2008
UF Decision Report FY06-07 Beneficiary Advisory Panel 10 Jan 2008 Promoting high quality, cost effective drug therapy throughout the Military Health System UF Decisions, May 07 Class FY05 rank, total $
More informationNetwork Health Insurance Corporation Upcoming Negative Changes to the Medicare Part D Formulary
Requesting an Exception to the Formulary You can ask Network Health Insurance Corporation to make an exception to our coverage rules. Generally, we will only approve your request for an exception if alternative
More informationCost Effectiveness Recommendations For Kentucky Retirement Systems MTM Plan 2011
Medication Tier 2 options Tier 1 options Nexium- Tier 3 Aciphex Lansoprazole Omeprazole Pantoprazole Crestor- Tier 3 Lipitor Simvastatin Vytorin- Tier 3 Atacand- Tier 3 Avapro Benicar Cozaar Micardis Tevetan
More informationTRICARE Uniform Formulary. Pre-Authorization Requirements
TRICARE Uniform Formulary Pre-Authorization Requirements The Department of Defense (DoD) requires pre-authorization on select medications. These medications are on the DoD s pre-authorization list because
More informationQuarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice The formulary changes listed in the table below were reviewed and approved at our second quarter 2018 Pharmacy and Therapeutics Committee meeting. Effective October
More informationTA Number. TA Link. Annotation
Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed 16 02 2017 Title Formulary Status Section TA Number TA Link Annotation Anti-infective preparations Anti-inflammatory
More informationUPDATE WellCare s South Carolina
September 3, 2015 UPDATE WellCare s South Carolina Preferred Drug List Dear Provider: At the September 3, 2015 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes
More informationTexas Prior Authorization Program Clinical Criteria. This criteria was recommended for review by an MCO to ensure appropriate and safe utilization.
Texas Prior Authorization Program Clinical Criteria Drug/Drug Class This criteria was recommended for review by an MCO to ensure appropriate and safe utilization. Clinical Information Included in this
More informationQuarterly pharmacy formulary change notice
MEDICAID PROVIDER BULLETIN October 2018 The formulary changes listed in the table below were reviewed and approved at the second-quarter 2018 Pharmacy and Therapeutics Committee meeting. Effective October
More informationQuarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice Provider update Summary: The formulary changes listed in the table below were reviewed and approved at our second quarter 2018, Pharmacy and Therapeutics Committee
More informationStep Therapy Criteria (Criteria for Step Therapy-2 [ST-2] Drugs)
CareAdvantage CMC 2018 Formulary Supplement II (List of Covered Drugs) Step Therapy Criteria (Criteria for Step Therapy-2 [ST-2] Drugs) Formulary ID: 00018157 Formulary Version:11 19 CMS Approved: 08/21/2018
More information2018 Step Therapy FID 18088
2018 Step Therapy FID 18088 Step Therapy ANTIDEPRESSANTS, SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS LEON 2018 Desvenlafaxine Er Fetzima Fetzima Titration Pack Khedezla Paxil SUSP Pristiq Trintellix
More informationQuarterly pharmacy formulary change notice
Provider Bulletin October 2018 Quarterly pharmacy formulary change notice The formulary changes listed in the table below apply to all Anthem HealthKeepers Plus patients. The changes listed in the table
More informationADDITIONAL DRUG LISTING FOR MEDICARE & MEDI-CAL MEMBERS
MEDICARE & MEDICAL MEMBERS! Please read carefully! The following pages include additional drugs which may be covered for you with your doctor s prescription by MediCal (Medicaid). These drugs CANNOT be
More information12.1 DRUGS ACTING ON THE EAR
12.1 DRUGS ACTING ON THE EAR Anti-inflammatory/anti-infective preparations These preparations usually contain a corticosteroid either alone or with an antibacterial agent. Betamethasone 0.1% ear, eye,
More informationGuide to the Modernized Reference Drug Program
Guide to the Modernized Reference Drug Program For prescribers and pharmacists Medical Beneficiary and Pharmaceutical Services Division June 1, 2016 Contents 1 Introduction 1 2 About this Guide 2 3 About
More informationII. Angiotensin Receptor Blockers (ARBs) Drug Class Review
DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE DOD BENEFICIARY ADVISORY PANEL I. Uniform Formulary Review Process Under 10 U.S.C. 1074g, as implemented by 32 C.F.R. 199.21,
More informationDrug Formulary Update, January 2017 Commercial and State Programs
Drug Formulary Update, January 2017 Commercial and State Programs Updates to the HealthPartners Commercial and State Program Drug Formularies are listed below. Updates apply to all Commercial groups (PreferredRx,
More informationAetna Better Health of Michigan 1333 Gratiot Avenue, Suite 400 Detroit, MI AETNA BETTER HEALTH January 2017 Formulary Change(s)
AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on July 1, 2017 ADAPALENE 0.1% CREAM ADAPALENE 0.1% GEL ATORVASTATIN 10
More informationTherapeutic Class Not Covered Examples of alternative options Analgesics - Anti-Inflammatory Nonsteroidal Anti-Inflammatory Agents (NSAIDS)
Date last updated: 3/23/18 Your benefit plan does not cover all drugs. Your benefit plan excludes coverage for drugs with one or more principal ingredients that are already available in greater/lesser
More informationARBS MEDICATION(S) SUBJECT TO STEP THERAPY DIOVAN HCT MG TAB, DIOVAN HCT MG TABLET
ARBS DIOVAN HCT 160-12.5 MG TAB, DIOVAN HCT 80-12.5 MG TABLET 30-day trial of a Step 1 drug in the previous 120 days is required. Step 1 Drugs: Losartan, Losartan/HCTZ PAGE 1 LAST UPDATED 05/2016 BILE
More informationPlan Year CCHP Senior Program (HMO) Step Therapy Criteria (ST)
Plan Year 2016 CCHP Senior Program (HMO) Step Therapy Criteria (ST) Step Therapy: In some cases, CCHP Senior Program (HMO) requires you to first try certain drugs to treat your medical condition before
More informationTennCare Program TN MAC Price Change List As of: 03/30/2017
1 TN List Run : 03/30/17 Old PRAZOSIN HCL 5 MG CAPSULE ORAL 03/29/2017 1.11209 1.12560 ( 1.2) CAPTOPRIL 12.5 MG TABLET ORAL 07/07/2015 1.07191 1.10416 ( 2.9) ISOSORBIDE DINITRATE 5 MG TABLET ORAL 03/29/2017
More informationRETAIL PRESCRIPTION PROGRAM DRUG LIST -- WALMART Revised 8/24/11
Allergies & Cold and Flu $4, 30-day $10, 90-day Benzonatate 100mg cap 14 42 Loratadine 10mg tab 30 90 Promethazine DM syrup 120ml 360ml Antibiotic Treatments Amoxicillin 125mg/5ml susp (80ml bottle) 1
More informationANTINEOPLASTIC DRUGS CHAPTER 21. Antineoplastic drugs - designed to treat malignancies, now also used to treat diseases with inflammatory component
ANTINEOPLASTIC DRUGS CHAPTER 21 Antineoplastic drugs - designed to treat malignancies, now also used to treat diseases with inflammatory component Tx of malignancies Antineoplastic drugs: methotrexate
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Reference Number: CP.CPA.209 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder at the end of this policy for important
More informationWellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum
WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum This is a listing of the changes that have occurred in our formulary. Please carefully review these changes and call WellCare if you
More informationDrug List exclusions for Blue Cross commercial plans
Drug List exclusions for Blue Cross commercial plans The drugs shown below aren t covered on the commercial Blue Cross Blue Shield of Michigan drug lists. In most cases, if you fill a prescription for
More informationACYCLOVIR OINT (CCHP2017)
ACYCLOVIR OINT (CCHP2017) acyclovir 5 % topical ointment Step Therapy requires trial of one (1) of the following: oral generic acyclovir, oral generic famciclovir, oral generic valacyclovir. 1 ALPHAGAN
More informationANTIDEPRESSANT THERAPY
Step Therapy Paramount Medicare Enhanced Formulary 2011 Formulary ID 11110, Ver 23. CMS Approved 10-25-2011. Last Updated: 10-05-2011 ANTIDEPRESSANT THERAPY Celexa Pristiq Cymbalta Prozac Effexor Prozac
More informationBioequivalence of Oral Generic Product with An Alternate Administration
Bioequivalence of Oral Generic Product with An Alternate Administration Minglei Cui, Ph.D. CDR, U.S. Public Health Service Division of Bioequivalence 2 Office of Generic Drugs CDER/FDA 1 Disclaimer & Disclosure
More informationGastric Bypass, Banded Gastric Bypass and Sleeve Gastrectomy Surgery Discharge Instructions
Columbia University Center for Metabolic and Weight Loss Surgery Columbia University Medical Center The Herbert Irving Pavilion 161 Fort Washington Ave, 5 th floor, Room 524 New York, New York 10032 Health
More informationProton Pump Inhibitors Drug Class Prior Authorization Protocol
Proton Pump Inhibitors Drug Class Prior Authorization Protocol Line of Business: Medi-Cal P&T Approval Date: November 15, 2017 Effective Date: January 1, 2018 This policy has been developed through review
More informationFORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs
More information2015 Chinese Community Health Plan Senior Program (HMO) Step Therapy Criteria Last Updated 11/1/2015
2015 Chinese Community Health Plan Senior Program (HMO) Step Therapy Last Updated 11/1/2015 APLENZIN TAB 174MG, 348MG, 522MG Step Therapy requires trial of bupropion SR or bupropion XL in previous 180
More informationHealth Partners Medicare Prime 2019 Formulary Changes
Health Partners Medicare Prime 2019 Formulary Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes
More informationCalgary Long Term Care Formulary
Page 1 of 14 Calgary Long Term Care Formulary Pharmacy & Therapeutics Highlights https://www.albertahealthservices.ca/info/page4071.aspx Page 2 of 14 Contents... 3 Formulary Changes (Additions, Changes,
More informationPharmacy Costs: Can I Make a Difference?
Pharmacy Costs: Can I Make a Difference? Pharmaceutical Market Dynamics What is driving Rx cost up? No New Blockbusters Patent Expirations OTC Market Dynamics Availability Pharmaceutical Companies Unfortunately,
More informationOTC PRODUCTS. 4 Gama Benzene HCL 0.1% + Proflavine Hermisulphate 0.1% + Cetrimide 0.45% Cream
OTC PRODUCTS SR. No. COMPOSITION Allantoin 0.2% + Dimethicone 1% + Urea 10% + Propylene Glycol 5% + Glyserine 5% + 1 Light Liquid Paraffin 8% Cream (FOOT CREAM) 2 Aquous Cream 3 Cetrimide 0.5% + Chlorhexidine
More informationRationale for Decision Excluded Generic OTC equivalent available (Flonase Allergy Relief) Medicare status (if differs)
BLUE SHIELD OF CALIFORNIA FIRST QUARTER 2015 FORMULARY AND MEDICATION POLICY UPDATES EFFECTIVE MARCH 19, 2015 The Blue Shield of California (BSC) Pharmacy and Therapeutics (P&T) Committee, consisting of
More informationEXECUTIVE SUMMARY. Uniform Formulary (UF) Beneficiary Advisory Panel (BAP) I. INTERIM MEETING: UF CLASS REVIEWS-PROTON PUMP INHIBITORS (PPis)
.. EXECUTIVE SUMMARY Uniform Formulary (UF) Beneficiary Advisory Panel (BAP) March 22, 2017 I. INTERIM MEETING: UF CLASS REVIEWS-PROTON PUMP INHIBITORS (PPis) PPis-UF Recommendation The P&T Committee recommended
More information